Φορτώνει......
Alzheimer's disease drug development pipeline: 2018
INTRODUCTION: Treatments for Alzheimer's disease (AD) are needed due to the growing number of individuals with preclinical, prodromal, and dementia forms of AD. Drug development for AD therapies can be examined by inspecting the drug development pipeline as represented on clinicaltrials.gov. ME...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Alzheimers Dement (N Y) |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021548/ https://ncbi.nlm.nih.gov/pubmed/29955663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.03.009 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|